Temporal and long-term gut microbiota variation in allergic disease: A prospective study from infancy to school age.


Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
01 2019
Historique:
accepted: 16 05 2018
pubmed: 23 5 2018
medline: 21 3 2020
entrez: 23 5 2018
Statut: ppublish

Résumé

Compositional changes in the early-life gut microbiota have been implicated in IgE-associated allergic diseases, but there is lack of longitudinal studies. We examined gut microbiota development from infancy to school age in relation to onset of IgE-associated allergic diseases. At 8 years of age, we also examined the relationship between gut microbiota and T-cell regulation, estimated as responses to polyclonal T-cell activation. Stool samples were collected from 93 children at 4, 6, 13 months, and 8 years of age. The gut microbiota was profiled using 16S rRNA gene sequencing. Peripheral blood was drawn from all children, and mononuclear cells were polyclonally activated. Levels of IL-10 and FOXP3 mRNA copies were determined using real-time quantitative reverse transcriptase-PCR. At 8 years of age, 21 children were diagnosed with IgE-associated allergic disease and 90% displayed allergic comorbidity. Seventy-two children were nonallergic and nonsensitized. Statistical tests with multiple testing corrections demonstrated temporal underrepresentation of Ruminococcus and consistent underrepresentation of Bacteroides, Prevotella, and Coprococcus in allergic compared to nonallergic children from infancy to school age. The gut microbiota of the allergic 8-year-olds was enriched in Bifidobacterium and depleted of Lactobacillus, Enterococcus, and Lachnospira. In allergic 8-year-olds, Faecalibacterium correlated with IL-10 mRNA levels (r We identified both temporal and long-term variation in the differential abundance of specific bacterial genera in children developing IgE-associated allergic disease. Improved dietary interventions aiming at expanding immune-modulatory taxa could be studied for prevention of allergic disease.

Sections du résumé

BACKGROUND
Compositional changes in the early-life gut microbiota have been implicated in IgE-associated allergic diseases, but there is lack of longitudinal studies. We examined gut microbiota development from infancy to school age in relation to onset of IgE-associated allergic diseases. At 8 years of age, we also examined the relationship between gut microbiota and T-cell regulation, estimated as responses to polyclonal T-cell activation.
METHODS
Stool samples were collected from 93 children at 4, 6, 13 months, and 8 years of age. The gut microbiota was profiled using 16S rRNA gene sequencing. Peripheral blood was drawn from all children, and mononuclear cells were polyclonally activated. Levels of IL-10 and FOXP3 mRNA copies were determined using real-time quantitative reverse transcriptase-PCR.
RESULTS
At 8 years of age, 21 children were diagnosed with IgE-associated allergic disease and 90% displayed allergic comorbidity. Seventy-two children were nonallergic and nonsensitized. Statistical tests with multiple testing corrections demonstrated temporal underrepresentation of Ruminococcus and consistent underrepresentation of Bacteroides, Prevotella, and Coprococcus in allergic compared to nonallergic children from infancy to school age. The gut microbiota of the allergic 8-year-olds was enriched in Bifidobacterium and depleted of Lactobacillus, Enterococcus, and Lachnospira. In allergic 8-year-olds, Faecalibacterium correlated with IL-10 mRNA levels (r
CONCLUSIONS
We identified both temporal and long-term variation in the differential abundance of specific bacterial genera in children developing IgE-associated allergic disease. Improved dietary interventions aiming at expanding immune-modulatory taxa could be studied for prevention of allergic disease.

Identifiants

pubmed: 29786876
doi: 10.1111/all.13485
doi:

Substances chimiques

Immunoglobulin E 37341-29-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

176-185

Subventions

Organisme : Semper AB and Arla Foods
Pays : International
Organisme : Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)
Pays : International
Organisme : Swedish Agency for Innovation Systems (VINNOVA)
Pays : International
Organisme : Swedish Research Council
Pays : International
Organisme : Natural and Engineering Sciences (VR-NT)
Pays : International
Organisme : Söderbergs foundation
Pays : International
Organisme : Swedish Research Council, Medicine (VR-M)
Pays : International
Organisme : the Västerbotten County Council (ALF)
Pays : International
Organisme : European Union's Seventh Frame Work Programme
ID : 222720
Pays : International
Organisme : Ekhaga Foundation
Pays : International
Organisme : Ronald McDonald Fund
Pays : International
Organisme : Swedish Nutrition Foundation
Pays : International
Organisme : Oskar-fonden
Pays : International

Informations de copyright

© 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Auteurs

K Simonyté Sjödin (K)

Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.

M-L Hammarström (ML)

Department of Clinical Microbiology, Immunology, Umeå University, Umeå, Sweden.

P Rydén (P)

Department of Mathematics and Mathematical Statistics, Umeå University, Umeå, Sweden.

A Sjödin (A)

Division of CBRN Security and Defense, FOI - Swedish Defense Research Agency, Umeå, Sweden.

O Hernell (O)

Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.

L Engstrand (L)

Department of Microbiology, Tumor and Cell Biology and Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.

C E West (CE)

Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH